For 1.7 mg: 1,700 / 16,667 = 0.102 mL = ~10 units
CagriSema is further along in the approval processNovo Nordisk submitted it to the FDA in December 2025but cagrilintide itself has its own clinical program
G., Chippa, V., & Correa, R
Considerations for Long-Term Users If you plan to use BPC-157 beyond a standard 46 week cycle, consider: Taking extended breaks between cycles Using the lowest effective dose Rotating injection sites to avoid local tissue fatigue or inflammation Monitoring subjective markers of progress and potential side effects (energy, GI symptoms, inflammation, blood pressure) Until clinical data becomes available, long-term safety remains uncertain so the guiding principle should be minimal effective use for specific, time-bound recovery goals
This happens when the needle cores the stopper